Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel.
/PRNewswire/ Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody.
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report)’s stock price rose 6.1% during mid-day trading on Monday . The company traded as high as $35.79 and last traded at $35.61. Approximately 30,426 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 444,849 shares. The stock had previously closed […]
Future Arca BioPharma ops 'highly dependent' on Oruka merger – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE) Shares Down 5% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.